| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | May 26, 2023 | |
| SC 13D/A | Report | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | Dec 20, 2022 | |
| SC 13D | Report | GROWTH EQUITY OPPORTUNITIES 18 VGE, LLC / X4 PHARMACEUTICALS, INC. -- SCHEDULE 1 | Jul 19, 2022 | |
| SC 13D/A | Report | SC 13D/A | Jul 17, 2019 | |
| SC 13D/A | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. - X4 PHARMACEUTICALS, INC. 13D/A1 | May 28, 2019 | |
| SC 13D/A | Report | SC 13D/A | Apr 26, 2019 | |
| SC 13D | Report | SC 13D | Mar 22, 2019 | |
| SC 13D/A | Report | AMENDMENT NO. 2 | Mar 19, 2019 | |
| SC 13D | Report | SCHEDULE 13D | Dec 6, 2018 | |
| SC 13D | Report | SC 13D | Feb 14, 2018 | |
| SC 13D/A | Report | AMENDMENT NO. 1 | Jan 26, 2018 | |
| SC 13D | Report | SCHEDULE 13D | Nov 30, 2017 | |
| SC 13D | Report | SC 13D | Nov 29, 2017 | |
| SC 13D | Report | NEW ENTERPRISE ASSOCIATES 16, L.P. - ARSANIS, INC. 13D | Nov 29, 2017 |